RealD Inc. announced that, in connection with its recent secondary offering, the underwriters have exercised, in full, their option to purchase an additional 1,172,250 shares of RealD common stock from certain existing stockholders.
For more information visit: www.reald.com
Unedited press release follows:
RealD Inc. Announces Exercise of Underwriters’ Option to Purchase Additional Shares in Recent Secondary Offering of Common Stock
LOS ANGELES–RealD Inc. (NYSE:RLD), a leading global licensor of 3D technologies, today announced that, in connection with its recent secondary offering, the underwriters have exercised, in full, their option to purchase an additional 1,172,250 shares of RealD common stock from certain existing stockholders. The 8,987,251 shares of RealD common stock in the secondary offering, including the 1,172,250 additional shares, were sold at the public offering price of $27.75 per share. RealD is not selling the additional shares and will not receive any proceeds from the sale of additional shares by selling stockholders.
J.P. Morgan Securities LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C. is acting as co-lead manager, and Stifel Nicolaus Weisel and BMO Capital Markets Corp. are acting as co-managers.
A registration statement relating to these securities has been declared effective by the Securities and Exchange Commission on December 6, 2010. The offering and sale of these securities will be made solely by means of a written prospectus forming part of the effective registration statement. A copy of the final prospectus related to the offering will be filed with the Securities and Exchange Commission and can be obtained, when available, from J.P. Morgan Securities LLC; J.P. Morgan, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by calling toll-free at 1-866-803-9204; or from Piper Jaffray & Co., Prospectus Department, 800 Nicollet Mall, Suite 800, Minneapolis, Minnesota 55402, telephone: 1-800-747-3924 or by email: prospectus@pjc.com.